Hemodynamic assessment in the medical treatment of acute myocardial infarction: the effects of various vasodilators and catecholamines.
D000328:Adult; D000368:Aged; D001775:Blood Circulation / Q000187:drug effects; D002395:Catecholamines / Q000627:therapeutic use*; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006341:Heart Rupture / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D008981:Molsidomine; D009025:Morpholines / Q000494:pharmacology; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D005996:Nitroglycerin / Q000008:administration & dosage / Q000627:therapeutic use; D009824:Ointments; D010646:Phentolamine / Q000494:pharmacology; D013558:Sydnones / Q000494:pharmacology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002395:Catecholamines; D009025:Morpholines; D009824:Ointments; D013558:Sydnones; D014665:Vasodilator Agents; D008981:Molsidomine; D005996:Nitroglycerin; D004298:Dopamine; D010646:Phentolamine